Global Blood Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
52.05 M |
Public Float |
44.65 M |
Global Blood Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.41 |
Market Cap |
$3.28 B |
Shares Outstanding |
56.41 M |
Public Float |
53.97 M |
Address |
171 Oyster Point Boulevard South San Francisco California 94080 United States |
Employees | - |
Website | http://www.gbt.com |
Updated | 07/08/2019 |
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. |